MARATTO

article · South African Journal of Chemistry

Occurrence of selected pharmaceuticals in wastewater and sludge samples from wastewater treatment plants in Eastern Cape province of South Africa

202420 citationsOpen accessUniversity of South Africa

Abstract

ABSTRACT The occurrence of pharmaceuticals in various wastewater treatment plants (WWTPs) and their discharge into the surface water are existing global challenges. However, such challenges are more detrimental in developing countries due to the aging infrastructure and its vandalism influenced by poverty, resulting in the illegal breakdown of the WWTPs. This study investigated the presence of efavirenz, ibuprofen, naproxen, sulfamethoxazole, and trimethoprim in WWTPs. Ultrasound-assisted extraction (UAE) followed by solid-phase extraction (SPE) was used to extract these pharmaceuticals in sludge samples, with wastewater extracted with only the latter. This was followed with analysis using a high-performance liquid chromatography-photo-diode array detection system. Recoveries found after spiking the samples with analytes at different concentrations ranged from 56 to 117%. An antibiotic, sulfamethoxazole, was among the prominent drugs in untreated wastewater with its concentration reaching 77 ug L-1. All the analytes were detected in sludge samples, with naproxen having the highest concentration of 13.35 ng g-1. The pharmaceutical with the lowest removal efficiency (2-12%) in WWTPs was efavirenz, while other drugs were fairly removed from wastewater. Overall, the findings of this study indicate the dysfunctionality of selected WWTPs in the Eastern Cape province of South Africa due to the release of high amounts of pharmaceuticals into the surface water which can be detrimental to humans, animals, and aquatic life.

Research topics

  • Pharmaceutical and Antibiotic Environmental Impacts

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.17159/0379-4350/2024/v78a02

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.